Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ilaprazole for Prevention of NSAID-Associated Peptic Ulcer
NCT06284876Phase 3Recruiting
- Sponsor
- Il-Yang Pharmaceutical
- Start
- Jul 2024
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ilaprazole in peptic ulcer disease (PUD), sponsored by Il-Yang Pharmaceutical. Started Jul 2024; status: recruiting.
02
Drugs
ilaprazole
03
Conditions
peptic ulcer disease (PUD)
Beyond the preview
Go deeper on NCT06284876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06284876.